Evidence mapPaperPMID 41102769Full record

ReviewDiabetology & metabolic syndrome2025

Continuous glucose monitoring in non-insulin-dependent type-2 diabetes - rationale for CGM-NIDDM study.

Carolin Rädel, Andreas Wienke, Rainer U Pliquett

Abstract readReview
In one paragraph

Review in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carolin RädelMartin-Luther-University Halle-Wittenberg, Ernst-Grube-Straße 40, Halle (Saale), 06120, Germany. carolinraedel@web.de.
Andreas WienkeInstitute of Medical Epidemiology, Biometry and Informatics, Martin-Luther-University Halle-Wittenberg, Ernst-Grube-Straße 40, Halle (Saale), 06120, Germany.
Rainer U PliquettMartin-Luther-University Halle-Wittenberg, Ernst-Grube-Straße 40, Halle (Saale), 06120, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type-2 diabetes is treated by general practitioners and diabetologists in a stepwise manner with an emphasis on lifestyle modifications. Glucose monitoring is mandatory to gauge the effect of lifestyle modifications or medical therapies in order to identify the need for therapy escalation, if treatment goals are not met. To date, three-monthly hemoglobin A1c measurements have been conducted for this purpose in the majority of non-insulin-dependent type-2 diabetes patients in Germany. Here, we review the role of continuous glucose monitoring in combination with nutrition counseling to offer a biofeedback. In addition, we present the rationale for a hypothesis-generating study that randomizes continuous glucose monitoring or no continuous glucose monitoring to the standard of nutrition counseling in individuals with prediabetes or non-insulin-dependent type-2 diabetes mellitus.

Indexed as

Continuous glucose monitoringHaemoglobin A1cNon-insulin-dependent type-2 diabetes mellitusNutrition counselingPrediabetes

Identifiers

PMID41102769
PMCPMC12529801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.